Oncology News

Recently published data showed a link between sustained virologic response and a reduced risk for hepatocellular carcinoma among patients treated with direct-acting antivirals for hepatitis C.

Nexavar treatment consistently showed benefit in hepatocellular carcinoma regardless of prognostic factors, according to results of a recently published study.

Late diagnosis of hepatitis B and hepatitis C has declined over time among patients with decompensated cirrhosis and those with hepatocellular carcinoma, according to a recently published study. Further, patients with more regular physician visits and lower risk activities were diagnosed earlier.

The United European Gastroenterology organization released a report stating that the average daily alcohol intake was between one and four drinks per person in all 28 European Union states, representing a 21% increased risk for developing digestive cancers.

Following HBsAg seroclearance, women aged older than 50 years and men with chronic hepatitis B had significant risk for developing hepatocellular carcinoma, whereas women aged 50 years or younger had no risk for HCC up to 5 years, according to results of a recently published study.

In patients treated with preoperative chemotherapy prior to resection for colorectal liver metastases, sinusoidal dilation and nodular regenerative hyperplasia did not regress until 9 months post-chemotherapy, while steatosis and steatohepatitis persisted even longer, according to a recent study.

Results of a recently published study showed an association between extensive preoperative chemotherapy in patients with colorectal liver metastases and hepatic atrophy, which was identified as a predictor of hepatic insufficiency and mortality.

The most significant risk factor for mortality in patients with hepatitis C-related cirrhosis and successfully treated hepatocellular carcinoma was hepatic decompensation within the first year of follow-up, according to a recently published study.

Direct-acting antiviral treatment in patients with hepatitis C and cirrhosis was most cost-effective and cost-saving pre-liver transplant among those with a MELD score of 21 or less, but post-liver transplant among those with a MELD score over 21, according to a recent study.

Computerized tomography and magnetic resonance imaging pelvic scans resulted in limited new findings of lesions or metastatic disease in patients with hepatocellular carcinoma, researchers reported in a recently published study.